Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/02/2022* -- Results Q3 2022 -- 1.15 --
11/02/2022* 08:00 EST Earnings Call Q3 2022 -- -- --
08/09/2022 -- Results Q2 2022 0.71 1.17 -39.48%
08/09/2022 08:00 EST Earnings Call Q2 2022 -- -- --
05/10/2022 -- Results Q1 2022 0.94 1.33 -28.97%
05/10/2022 08:00 EST Earnings Call Q1 2022 -- -- --
02/23/2022 -- Results Q4 2021 1.62 1.46 10.84%
02/23/2022 08:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/02/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/09/2022
Beat/Miss Upgrade
Return Since 51.79%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.
URL https://www.bauschhealth.com
Investor Relations URL https://ir.bauschhealth.com
HQ State/Province Quebec
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Value
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 10, 2010

Dividends

Dividend Per Share (TTM) 0.00
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date Nov. 10, 2010
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-15.49%
-86.15%
34.57%
-3.63%
53.94%
-32.06%
32.30%
-70.89%
-7.76%
21.36%
9.78%
-7.58%
21.93%
5.56%
28.04%
-10.10%
--
--
--
--
--
--
--
--
-25.71%
-72.12%
27.59%
175.7%
167.2%
-60.96%
165.5%
43.76%
50.00%
283.3%
317.4%
-29.38%
-58.85%
-68.34%
-35.38%
-74.16%
--
--
3.15K%
47.69%
-55.21%
27.91%
-52.73%
-73.08%
As of September 28, 2022.

Profile

Edit
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.
URL https://www.bauschhealth.com
Investor Relations URL https://ir.bauschhealth.com
HQ State/Province Quebec
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Value
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 10, 2010

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
CHO154 2.152M CAD 6.34%
PJP 15.25M CAD 4.92%
ACTV 3.548M CAD 4.69%
CHO104 5.542M CAD 3.78%
FCCV.TO 2.274M CAD 2.64%
MKC.TO 9.571M CAD 2.07%
BRUFX 10.45M CAD 1.98%
BIP621 475400.0 CAD 1.01%
PPH 4.292M CAD 0.77%
VVL.TO 1.168M CAD 0.41%
UPUPX 38750.00 CAD 0.40%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership